NASDAQ
No price data available for this timeframe.
Beam Therapeutics Inc. (BEAM) has a eps (basic) of $-0.81 as of Wednesday, December 31, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.